Search Results for: -trrxht.html

CHICAGO, IL and FORT WORTH, TX, April 3, 2017 – Actuate Therapeutics, Inc., a Chicagobased biopharmaceutical company, today announced that an article authored by its scientific founders titled “Molecular Pathways: Revisiting Glycogen Synthase Kinase-3β as a Target for the Treatment of Cancer” was published on March 31, 2017 in the Molecular Pathways special feature in

CHICAGO, IL and FORT WORTH, TX, March 1, 2017 – Actuate Therapeutics, Inc., a Chicago-based biopharmaceutical company, today announced the appointment of Francis J. Giles, MB, MD, FRCPI, FRCPath to the newly created position of Chief Medical Officer (CMO). Dr. Giles will be responsible for advancing Actuate’s research and development initiatives, leading the clinical programs,